IBVIS Trademark

Trademark Overview


On Tuesday, August 11, 2020, a trademark application was filed for IBVIS with the United States Patent and Trademark Office. The USPTO has given the IBVIS trademark a serial number of 79296446. The federal status of this trademark filing is REGISTERED as of Tuesday, May 31, 2022. This trademark is owned by Veritas In Silico Inc.. The IBVIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Designing of machines, apparatus, instruments, machine parts, and systems composed of such machines, apparatus and instruments; pharmaceutical, medicine, chemical and engineering design services; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for analyzing and assaying m...
ibvis

General Information


Serial Number79296446
Word MarkIBVIS
Filing DateTuesday, August 11, 2020
Status700 - REGISTERED
Status DateTuesday, May 31, 2022
Registration Number6741536
Registration DateTuesday, May 31, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements


Goods and ServicesDesigning of machines, apparatus, instruments, machine parts, and systems composed of such machines, apparatus and instruments; pharmaceutical, medicine, chemical and engineering design services; computer software design, computer programming, and maintenance of computer software; designing, programming and maintenance of computer software having artificial intelligence functionality; computer software design, computer programming, and maintenance of computer software for use in scientific and technical analysis of data from artificial intelligence; computer software design, computer programming, and maintenance of computer software for use in analysis, testing, screening, designing, development or research on nucleic acids, pharmaceuticals or chemicals; computer software design, computer programming, and maintenance of computer software for use in drug discovery screening; computer software design, computer programming, and maintenance of computer software for analyzing and assaying messenger RNA (mRNA) substructures; computer program design, computer programming, and maintenance of computer program for databases; computer software design, computer programming, and maintenance of computer software for use in genome research or the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; information processing using computers, namely, providing online nondownloadable software for processing of data regarding RNA and RNA-compound interaction by computers for use in developing new drugs; technical advice relating to computers, computers for automobiles and other computers for industrial machines requiring highly specialized knowledge, skills and experiences for proper operation; scientific and technical research consultancy in the field of life information science, nucleic acids diagnosis and drug discovery, and research and development relating thereto; analysis and research in the field of life information science and technology, namely, analysis and research on target identification and validation, and prediction of structure and function of proteins and nucleic acids; laboratory research and development of new products for others in the field of life information science, nucleic acids diagnosis and drug discovery; scientific and technological services, namely, biochemical and biological testing, inspection of medical and chemical goods for quality control purposes, efficacy and quality analysis of medical and chemical products, medical and chemical product development and research; chemical analysis and screening on chemicals, namely, chemical product quality evaluation; screening on pharmaceuticals, namely, pharmaceutical product evaluation; scientific research, testing and analysis in the field of nucleic acids, pharmaceuticals, drug discovery and development, medicines, chemicals and engineering; research services in the field of biological science, namely, isolation, purification, analysis, screening and research on DNA, RNA and other biological materials; quality assessment services, namely, quality control and evaluation for others; testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; development and research on pharmaceuticals targeting messenger RNA (mRNA) substructures, and providing information and consultancy relating thereto; Scientific and technological services, namely, testing, inspection, analysis, surveying, development and research on small molecule compounds, antisense oligonucleotides and compounds, and providing information and consultancy relating thereto; analysis, surveying and development of pharmaceuticals, and providing information and consultancy relating thereto; testing, inspection and research for drug development and medical research purposes, and providing information and consultancy relating thereto; testing and research on biotechnology and providing information and consultancy relating thereto; medical and biological research in the nature of genomic experiments, analyses, research, assays, testing, inspection and detection of medical and biological products for efficacy and quality evaluation; consultancy, advice and providing information on medical and biological research in the nature of genomic experiments, analyses, research, assays, testing, inspection and detection of medical and biological products for efficacy and quality evaluation; testing, surveying, research and data analysis for research purposes in the field of biomedicine, genome biology, pharmacogenomics, diagnostics, clinical trials or bioengineering; testing, inspection and research of chemicals or reagents; research and development of vaccines and medicines; research and development of vaccines and medicines; consultancy and providing information on testing, inspection and research of pharmaceuticals, chemicals, reagents, cosmetics or foodstuffs; conducting clinical trials for others on pharmaceuticals; research on building construction or city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; testing the functionality of and research on machines, apparatus and instruments; rental of measuring apparatus; rental of computers; providing computer programs on data networks, namely, providing temporary use of non-downloadable computer software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; cloud computing, namely, providing temporary use of on-line non-downloadable cloud computing software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; software as a service (SaaS) services featuring software for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; electronic storage services for archiving electronic data; providing electronic data server storage services on the internet; providing temporary use of non-downloadable computer software having artificial intelligence functionality on data networks for use in research and development of nucleic acids, pharmaceuticals, medicines and chemicals; providing temporary use of online non-downloadable computer software for analysis of science and technology data based on artificial intelligence (AI) technology; providing temporary use of online non-downloadable computer software for use in analysis, testing, screening, designing, development or research of nucleic acids, pharmaceuticals or chemicals; providing temporary use of online non-downloadable computer software for use in drug discovery screening; providing temporary use of online non-downloadable computer programs on data networks for analyzing and assaying messenger RNA, or mRNA, substructures; providing temporary use of online non-downloadable computer programs for creating, accessing, managing and searching databases; providing temporary use of online non-downloadable computer software for use in genome research and the development of consumer health products, treatments, pharmaceutical preparations, diagnostic instruments or foodstuffs; rental of laboratory apparatus and instruments

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 26, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVeritas In Silico Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameVeritas In Silico Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameVeritas In Silico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, October 22, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, October 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 30, 2020APPLICATION FILING RECEIPT MAILED
Monday, December 14, 2020NON-FINAL ACTION WRITTEN
Sunday, December 6, 2020ASSIGNED TO EXAMINER
Tuesday, December 15, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, June 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 28, 2020REFUSAL PROCESSED BY MPU
Tuesday, December 29, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 15, 2021REFUSAL PROCESSED BY IB
Wednesday, June 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 27, 2021PRIORITY ACTION WRITTEN
Tuesday, July 27, 2021PRIORITY ACTION E-MAILED
Tuesday, July 27, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, January 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 4, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, February 4, 2022EXAMINERS AMENDMENT E-MAILED
Friday, February 4, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 4, 2022EXAMINER'S AMENDMENT ENTERED
Sunday, February 6, 2022ASSIGNED TO LIE
Wednesday, February 23, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, April 10, 2022NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, March 21, 2022NOTIFICATION PROCESSED BY IB
Wednesday, March 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, March 23, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 31, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 31, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 31, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 11, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, October 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 10, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 15, 2022FINAL DISPOSITION PROCESSED
Thursday, September 15, 2022FINAL DISPOSITION NOTICE SENT TO IB